مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

354
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

115
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

DEVELOPMENT OF RADIOLABELED RECOMBINANT ERYTHROPOIETIN FOR RECEPTOR STUDIES

Pages

  73-79

Abstract

 The study of human erythropoietin receptor is of great importance in evolution, carcinogenesis as well as endocrine research. In this study the production and quality control of human recombinant erythropoietin (EPO) has been reported. EPO was successively labeled with [67Ga]-gallium chloride after conjugation with freshly prepared cyclic DTPA-dianhydride (ccDTPA). The best results of the conjugation were obtained by the addition of 0.5 ml of a EPO pharmaceutical solution (in phosphate buffer, pH=8) to a glass tube pre-coated with DTPA-dianhydride (0.01 mg) at 25oC with continuous mild stirring for 30 min followed by HPLC/RTLC control and biological BIODISTRIBUTION in normal rats. Under optimized conditions, radio-thin layer chromatography (RTLC), instant thin layer chromatography (ITLC) and high performance liquid chromatography (HPLC) showed overall radiochemical purity of higher than 96% (specific activity=300-500 MBq/mg, labeling efficiency 77%). Preliminary in vivo studies in normal rat specimen demonstrated a high liver, lung spleen, kidney as well as long bones uptake of the tracer; the fact which is consistent with the reported EPO receptor sites. This tracer can be used in nuclear medicine and biological studies for evaluation of EPO in vitro and/or in vivo.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    JALILIAN, A.R., SADEGHPOUR, H., AKHLAGHI, M., & GHOLAMI, E.. (2012). DEVELOPMENT OF RADIOLABELED RECOMBINANT ERYTHROPOIETIN FOR RECEPTOR STUDIES. JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY, -(3 (61)), 73-79. SID. https://sid.ir/paper/659030/en

    Vancouver: Copy

    JALILIAN A.R., SADEGHPOUR H., AKHLAGHI M., GHOLAMI E.. DEVELOPMENT OF RADIOLABELED RECOMBINANT ERYTHROPOIETIN FOR RECEPTOR STUDIES. JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY[Internet]. 2012;-(3 (61)):73-79. Available from: https://sid.ir/paper/659030/en

    IEEE: Copy

    A.R. JALILIAN, H. SADEGHPOUR, M. AKHLAGHI, and E. GHOLAMI, “DEVELOPMENT OF RADIOLABELED RECOMBINANT ERYTHROPOIETIN FOR RECEPTOR STUDIES,” JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY, vol. -, no. 3 (61), pp. 73–79, 2012, [Online]. Available: https://sid.ir/paper/659030/en

    Related Journal Papers

  • No record.
  • Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button